Tumor-Infiltrating Lymphocytes (TILs) are a heterogeneous population of immune cells, predominantly T-cells, that have extravasated from the peripheral circulation and infiltrated the tumor stroma and parenchyma. Their presence represents the host's adaptive immune response against neoplastic cells. In computational pathology, TILs are quantified as a continuous biomarker by analyzing H&E-stained whole slide images (WSIs) using deep learning models trained to segment and classify stromal versus intratumoral compartments.
Glossary
Tumor-Infiltrating Lymphocytes (TILs)

What is Tumor-Infiltrating Lymphocytes (TILs)?
Tumor-Infiltrating Lymphocytes (TILs) are immune cells that have migrated from the bloodstream into a tumor microenvironment, serving as a critical prognostic and predictive biomarker in oncology.
Automated TIL quantification via convolutional neural networks and vision transformers provides a reproducible, spatial assessment of the immune landscape, overcoming the inter-observer variability of manual scoring. High TIL density is a strong positive prognostic factor in triple-negative breast cancer and is predictive of response to immune checkpoint inhibitors. This computational approach transforms a qualitative histological observation into a precise, actionable metric for precision immuno-oncology.
Key Characteristics of TILs as a Biomarker
Tumor-Infiltrating Lymphocytes (TILs) serve as a critical biomarker in immuno-oncology, reflecting the host's immune response to the tumor. Computational pathology enables the objective, high-throughput quantification of their density, spatial distribution, and subtype composition, moving beyond subjective visual estimation.
Prognostic Significance
The density of stromal TILs is a strong prognostic biomarker, particularly in triple-negative breast cancer (TNBC) and HER2-positive subtypes. High TIL levels are independently associated with improved disease-free and overall survival. Computational analysis provides a continuous, quantitative score, offering superior risk stratification compared to categorical visual assessment by pathologists.
Predictive Value for Immunotherapy
TIL quantification is a powerful predictive biomarker for response to immune checkpoint inhibitors (ICIs). A pre-existing, inflamed tumor microenvironment, characterized by high TIL infiltration, often indicates a higher likelihood of response to anti-PD-1/PD-L1 therapies. AI-driven spatial analysis can further refine this by mapping the proximity of CD8+ cytotoxic T cells to tumor cells.
Spatial Architecture Analysis
Beyond simple density, the spatial organization of TILs is a critical determinant of function. Computational pathology tools analyze spatial patterns, including:
- Immune Exclusion: TILs trapped in the stroma, unable to contact tumor cells.
- Immune Desert: A complete absence of TILs.
- Inflamed Phenotype: TILs infiltrating directly into tumor cell nests. These architectures, quantified via spatial statistics, provide deeper insight than density alone.
Standardization via Computational Pathology
Manual TIL scoring by pathologists suffers from significant inter-observer variability. Machine learning models trained on expert-annotated whole slide images (WSIs) provide a reproducible, automated solution. These systems perform automated tissue segmentation to identify stroma and tumor regions, then execute cell detection and classification to generate a standardized, objective TIL score, crucial for clinical trial enrollment and treatment decisions.
Integration with Multi-Modal Data
TIL metrics derived from H&E-stained images are increasingly integrated with other data modalities to build holistic predictive models. Key integrations include:
- Genomics: Correlating TIL density with Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) status.
- Transcriptomics: Linking spatial TIL patterns with gene expression signatures of immune activation.
- Radiomics: Fusing pathology-based TIL scores with features from CT/MRI scans for a whole-patient view of the immune landscape.
Quantifying Immune Subtypes
Advanced deep learning models, often using Multiple Instance Learning (MIL) with attention mechanisms, can go beyond total TIL counts to infer the presence of specific immune cell subtypes from standard H&E stains. This includes distinguishing lymphocytes, plasma cells, and granulocytes, providing a detailed, low-cost immune profile without requiring multiplex immunohistochemistry (mIHC) stains.
Frequently Asked Questions
Concise answers to the most common technical questions about Tumor-Infiltrating Lymphocytes and their quantification via computational pathology.
Tumor-Infiltrating Lymphocytes (TILs) are a diverse population of immune cells, primarily T-cells and B-cells, that have migrated from the peripheral bloodstream into the tumor microenvironment. They represent the host's endogenous immune response against malignant cells. Mechanistically, CD8+ cytotoxic T-cells recognize tumor-specific antigens presented on Major Histocompatibility Complex (MHC) class I molecules, triggering the release of perforin and granzyme to induce apoptosis in cancer cells. The presence, density, and spatial organization of these lymphocytes serve as a critical biomarker, indicating an ongoing anti-tumor immune response. In computational pathology, TILs are quantified not just by simple density but by analyzing their spatial relationships with tumor cells, as a high density of TILs within the tumor core is often associated with a favorable prognosis and a higher likelihood of response to immunotherapies like checkpoint inhibitors.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Related Terms
Key computational pathology concepts that intersect with Tumor-Infiltrating Lymphocyte quantification and analysis.
Multiple Instance Learning (MIL)
A weakly supervised learning paradigm essential for TIL analysis where a model is trained on labeled bags of instances. In computational pathology, a whole slide image is treated as a bag containing thousands of unlabeled tissue patches. The model learns to aggregate patch-level features into a slide-level prediction—critical for TIL scoring when only slide-level labels are available.
- Enables training without exhaustive pixel-level annotations
- Attention-based MIL dynamically weights diagnostically relevant regions
- Foundation for frameworks like CLAM and TransMIL
Tumor-Stroma Ratio
A prognostic biomarker quantifying the proportion of tumor cells relative to surrounding connective tissue within a tumor region. Automatically assessed via tissue segmentation algorithms, this ratio provides complementary information to TIL density. A high stroma fraction often correlates with immune-excluded phenotypes where lymphocytes are trapped in the stromal compartment rather than infiltrating tumor nests.
- Calculated as stroma area divided by total tumor area
- Deep learning segmentation enables reproducible, automated assessment
- Combined with TIL analysis for comprehensive microenvironment profiling
Immunohistochemistry (IHC)
A staining method using antibodies to detect specific protein antigens in tissue sections, serving as the ground truth validation for TIL subtyping. While H&E-based TIL quantification estimates total lymphocyte density, IHC markers like CD3, CD8, and FOXP3 precisely identify T-cell subsets. Computational pathology increasingly uses IHC as a reference standard for training models that predict immune phenotypes from routine stains.
- CD8+ cytotoxic T-cells are the most prognostically significant TIL subset
- PD-L1 IHC scoring is a companion diagnostic for immunotherapy eligibility
- Multi-plex IHC enables simultaneous visualization of multiple immune markers
Stain Normalization
A computational pre-processing technique that standardizes color appearance across pathology images from different laboratories. TIL quantification models are highly sensitive to color variation caused by different staining protocols, scanner types, and reagent batches. Stain normalization ensures that a model trained on one institution's data generalizes reliably to external cohorts.
- Macenko and Vahadane are widely used normalization algorithms
- Preserves morphological structure while aligning color distributions
- Essential for multi-institutional TIL biomarker validation studies
Graph Neural Network (GNN)
A deep learning architecture that models relationships between tissue patches as a graph, explicitly capturing the spatial architecture of the tumor microenvironment. Unlike MIL approaches that treat patches independently, GNNs encode the spatial proximity and clustering patterns of TILs relative to tumor cells. This enables the detection of immune-excluded, immune-desert, and immune-inflamed phenotypes.
- Nodes represent tissue patches; edges encode spatial adjacency
- Captures cell-to-cell interaction topology critical for immunotherapy response prediction
- Emerging as a superior approach for TIL spatial analysis compared to density alone
Uncertainty Quantification
Techniques that estimate a model's confidence in its TIL density predictions, crucial for clinical deployment. High uncertainty may indicate ambiguous tissue regions, rare morphological patterns, or out-of-distribution samples. Uncertainty-aware models can triage difficult cases for pathologist review, building clinical trust while maintaining workflow efficiency.
- Epistemic uncertainty reflects model knowledge gaps from limited training data
- Aleatoric uncertainty captures inherent noise in tissue appearance
- Enables selective prediction where low-confidence cases are deferred to human experts

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us